CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $17.21 ($137,680)
- 4 Option exercise Director acquired 1,333 shares (option exercise)
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $17.23 ($137,840)
- 4 Open-market buy Director bought 9,506 shares at $16.80 ($159,701)
- 4 Planned sale Chief Commercial Officer sold 2,400 shares at $20.05 ($48,120)
- 4 Planned sale President/CEO and Board Chair sold 103,900 shares at an average $20.01 ($2,078,984)
- 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $17.35 ($156,150)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $18.63 ($149,040)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
Page 8 of 17 · 330 filings